Ryan Allway July 4th, 2020 Psychedelics Cybin Corp. (“Cybin”), a mushroom life sciences company focused on psychedelic medicines and nutraceutical products, is pleased to announce that it has entered into an amalgamation agreement dated June 26, 2020 (the “AmalgamationAgreement”) with Clarmin Explorations Inc. (TSX.V: CX) (“Clarmin”) and 2762898 Ontario... Read more
Ryan Allway July 2nd, 2020 Psychedelics, Top News New program offers psychedelic-assisted psychotherapy that enables ‘frontliners’ and others in high-pressure occupations to “return, reset and relaunch” TORONTO , July 2, 2020 /PRNewswire/ — Field Trip Psychedelics Inc. (“Field Trip” or the “Company“), the company redefining mental health and well-being... Read more
PsyIndex Weekly Update
June 29, 2020
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any... Read more
Pure Extracts Enters Functional Mushroom Space Backstopped by Expertise in Cannabis Extraction
June 29, 2020
Ryan Allway June 29th, 2020 App, Exclusive, Psychedelics, Top Story There are only a few times that investors get an opportunity to get in front of an emerging industry. Think about cannabis or electric vehicles in recent times. There can be tremendous upside, but there is generally a steep... Read more
3 Ways to Invest in the Nascent Psychedelics Industry
June 25, 2020
Ryan Allway June 25th, 2020 Psychedelics, Top News The psychedelics industry is projected to grow from about $2 billion in 2019 to nearly $7 billion by 2027, according to Data Bridge Market Research, representing a 16.3% compound annual growth rate. With ongoing clinical trials and support from the FDA,... Read more
Advisors including Dr. Gabor Maté and Zach Walsh bring training and expertise in psychedelic-assisted therapy and mental health treatment VANCOUVER, BC, June 24, 2020 /CNW/ – Numinus Wellness Inc. (“Numinus”) (TSX-V: NUMI) is pleased to announce its Clinical Advisory Council, chaired by Numinus Chief Medical Officer Dr. Evan Wood. Leveraging the expertise of its members, the... Read more
Ryan Allway June 23rd, 2020 App, Exclusive, Psychedelics, Top Story Millions of people have had a psychedelic experience at some point in their life and with new FDA approved medicines and regulatory changes millions more will soon be able to as well. However, without support, it can be challenging... Read more
New Wave Holdings Corp Appoints Dr. Dennis McKenna to Psychedelic Research Advisory Board
June 22, 2020
Ryan Allway June 22nd, 2020 Psychedelics NEW WAVE HOLDINGS CORP. (the “Company” or “New Wave Holdings“) (CSE: SPOR) (Frankfurt: 0XM2) (OTC: TRMND), is an investment issuer focused on emerging sectors including the psychedelic sector, is pleased to announce that it has brought on Dr. Dennis McKenna, Ph.D. to its... Read more
Ryan Allway June 22nd, 2020 Psychedelics NEW WAVE HOLDINGS CORP. (the “Company” or “New Wave“) (CSE: SPOR) (Frankfurt: 0XM2) (OTC: TRMND), an investment issuer focused on emerging sectors including the psychedelic sector, is pleased to announce that it has welcomed Dr. Carolyn Myers, Ph.D. to provide business strategy and... Read more
Champignon Announces Regulatory Review
June 22, 2020
Ryan Allway June 22nd, 2020 Psychedelics, Top News VANCOUVER, British Columbia, June 22, 2020 (GLOBE NEWSWIRE) — Champignon Brands Inc. (“Champignon” or the “Company”) (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF) announces that it has been selected for a continuous disclosure review by the British Columbia Securities Commission (the “Commission”).... Read more
